For research use only. We do not sell to patients.
| Name | LGD-4033(Ligandrol) |
|---|---|
| Iupac Chemical Name | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile |
| Synonyms | LGD-4033;LGD 4033;LGD4033;VK5211;VK-5211;VK 5211;Ligandrol |
| Molecular Formula | C14H12F6N2O |
| Molecular Weight | 338.248 |
| Smile | C1CC(N(C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)C(C(F)(F)F)O |
| InChiKey | OPSIVAKKLQRWKC-UHFFFAOYSA-N |
| InChi | InChI=1S/C14H12F6N2O/c15-13(16,17)10-6-9(4-3-8(10)7-21)22-5-1-2-11(22)12(23)14(18,19)20/h3-4,6,11-12,23H,1-2,5H2 |
| CAS Number | 1165910-22-4 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |